New York’s blood shield statute bars product liability lawsuits not only against laboratories that supply blood and the hospitals and doctors who transfuse patients, but also against “fractionators,” which process and distribute blood products, a Manhattan Supreme Court justice has ruled in statewide litigation over allegedly contaminated blood.

In dismissing strict liability and breach of warranty causes of action, Justice Karla Moskowitz said that Public Health Law �580(4) does not only regulate clinical laboratories and blood banks, but also the fractionators.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]